RVTY vs VIR · P/E 42, rev $1.44B vs rev $238.9M
Revvity Inc. (RVTY) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
RVTY currently screens at market cap $11.94B and trailing P/E 41.9. VIR currently screens at market cap $1.45B.
Not investment advice. Open the RVTY and VIR stock pages for the full models.
Not investment advice.